Re: Oscar Reig Torras, Akhilesh Mishra, Alana Christie, et al. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.003

Affiliations

¹ Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
² Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Electronic address: beijingzhangyushi@126.com.

Comment

Zhan Wang et al. Eur Urol. 2022 May.

. 2022 May;81(5):e120.

doi: 10.1016/j.eururo.2022.01.047. Epub 2022 Feb 26.

¹ Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
² Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Electronic address: beijingzhangyushi@126.com.

No abstract available

Comment on

Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.
Reig Torras O, Mishra A, Christie A, McKenzie T, Onabolu O, Singla N, Plimack ER, Suárez C, Ornstein MC, Alpaugh RK, Elias R, Bowman IA, McKay RM, Przybycin C, Kapur P, Brugarolas J, Rini B. Reig Torras O, et al. Eur Urol. 2022 Jun;81(6):555-558. doi: 10.1016/j.eururo.2021.12.003. Epub 2021 Dec 31. Eur Urol. 2022. PMID: 34980496 Free PMC article. Clinical Trial.
Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Bui TO, Dao VT, Nguyen VT, Feugeas JP, Pamoukdjian F, Bousquet G. Bui TO, et al. Eur Urol. 2022 Apr;81(4):349-361. doi: 10.1016/j.eururo.2021.12.010. Epub 2022 Jan 3. Eur Urol. 2022. PMID: 34991918